News
![Growth is good, but GSK really needs to build its pipeline](/sites/default/files/styles/x_large/public/2023-02/Emma%20Walmsley.jpg?itok=dhKPIqNh)
Growth is good, but GSK really needs to build its pipeline
GSK continued a run of several consecutive quarters of solid growth in the fourth quarter of 2022, helped by shingles vaccine Shingrix, but it needs to build up its pipeli